Matthew Taylor
Stock Analyst at Jefferies
(2.68)
# 1,890
Out of 5,165 analysts
184
Total ratings
59.82%
Success rate
10.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Buy | $220 → $190 | $161.64 | +17.55% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Hold | $335 → $374 | $338.00 | +10.65% | 2 | Jan 16, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $72.34 | +45.15% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $230.49 | +54.02% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $84.27 | +16.29% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $15.12 | +25.66% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $110.71 | +30.97% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $13.65 | +9.89% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $88.44 | -14.07% | 17 | May 24, 2024 | |
| MASI Masimo | Downgrades: Hold | $107 → $121 | $175.97 | -31.24% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.61 | +203.69% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $23.91 | +88.21% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $6.49 | +54.08% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $9.10 | +482.42% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $11.34 | +111.64% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $349.11 | -1.18% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $92.52 | +40.51% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $12.84 | +55.76% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $37.34 | +127.64% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $88.16 | -14.93% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $233.50 | +4.93% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $17.62 | +251.87% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $109.00 | +92.66% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $13.05 | -8.05% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $67.32 | +85.68% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $71.20 | -29.78% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $482.76 | -56.50% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $62.43 | +53.77% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $4.27 | +63.93% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $10.71 | +49.39% | 2 | Jul 19, 2017 |
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Buy
Price Target: $220 → $190
Current: $161.64
Upside: +17.55%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $335 → $374
Current: $338.00
Upside: +10.65%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $72.34
Upside: +45.15%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $230.49
Upside: +54.02%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $84.27
Upside: +16.29%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $15.12
Upside: +25.66%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $110.71
Upside: +30.97%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $13.65
Upside: +9.89%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $88.44
Upside: -14.07%
Masimo
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $175.97
Upside: -31.24%
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.61
Upside: +203.69%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $23.91
Upside: +88.21%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $6.49
Upside: +54.08%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $9.10
Upside: +482.42%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $11.34
Upside: +111.64%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $349.11
Upside: -1.18%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $92.52
Upside: +40.51%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $12.84
Upside: +55.76%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $37.34
Upside: +127.64%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $88.16
Upside: -14.93%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $233.50
Upside: +4.93%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $17.62
Upside: +251.87%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $109.00
Upside: +92.66%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $13.05
Upside: -8.05%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $67.32
Upside: +85.68%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $71.20
Upside: -29.78%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $482.76
Upside: -56.50%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $62.43
Upside: +53.77%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $4.27
Upside: +63.93%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $10.71
Upside: +49.39%